MedTrace Logo

REal World Information on Cardiovascular Drug Management Patterns in Acute Coronary Syndrome paTients

NCT02001545 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 814

Last updated 2014-11-14

No results posted yet for this study

Summary

RE-ACT is a national, multi-centre, observational, prospective, longitudinal cohort study which will include patients hospitalized for ACS within 24 hours of symptom onset and who have a final diagnosis of ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardial infarction (NSTEMI). This study aims to describe the short-term (at the end of the first month after index event) antithrombotic management patterns in a "real-life" setting for patients hospitalized with an acute coronary syndrome.

Conditions

  • Acute Coronary Syndrome

Sponsors & Collaborators

Principal Investigators

  • Elina Trendafilova, Ass. Prof. M.D · National Cardiology Hospital, Sofia

  • Vasil Velchev, Ass. Prof. M.D. · University Hospital St. Anna

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • Bulgaria

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02001545 on ClinicalTrials.gov